Prenatal exclusion testing for Huntington disease using the polymerase chain reaction.
Prenatal exclusion of Huntington disease (HD) may be carried out by analysis of cosegregating DNA markers on a first-trimester chorionic villus sample. The conventional Southern blot method is time-consuming and requires microgram quantities of DNA and milligram quantities of villus tissue. The use of the polymerase chain reaction (PCR) to amplify genomic DNA by a factor of 10(7) or more makes it possible to do analyses on very small samples in a few hours and without recourse to Southern blotting or hybridization with radioactive probes. We report on a fetus at risk of HD; prenatal testing was carried out by using the PCR to amplify a polymorphic DNA sequence adjacent to the HD locus. The risk of the fetus inheriting the HD gene could not be excluded and the pregnancy was terminated. This represents an example of gene tracking by using amplification of a restriction fragment length polymorphism at some distance from the relevant mutation.
McIntosh
I
I
Human Genetics Unit, University of Edinburgh, Western General Hospital, U.K.
Curtis
A
A
Millan
F A
FA
Brock
D J
DJ
D000328:Adult; D015193:Chorionic Villi Sampling; D004247:DNA / Q000235:genetics*; D004259:DNA-Directed DNA Polymerase; D005260:Female; D005784:Gene Amplification; D005819:Genetic Markers; D006801:Humans; D006816:Huntington Disease / Q000235:genetics*; D010375:Pedigree; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D011296:Prenatal Diagnosis
D005819:Genetic Markers; D004247:DNA; D004259:DNA-Directed DNA Polymerase